Tuesday 23 January 2018

Thermal Barrier Coatings Market Expected To Grow Due To Owing To The Increased vapor deposition technologies for coating application Till 2024: Grand View Research, Inc.

The global thermalbarrier coatings market is expected to reach a market size of USD 22.30 billion by 2024, according to a new report by Grand View Research, Inc. The industry is expected to witness significant growth over the forecast period owing to the increased adoption of air plasma and vapor deposition technologies for coating application, thereby increasing the demand from various application segments, globally.
The rising demand from gas turbine applications across stationary power plants, aerospace, and automotive industries is also expected to propel demand over the forecast years. The technological advancements in the industry have widened the application scope of these coating products in the aforementioned segments. This is expected to offer significant growth potential for industry players in the industry during the forecast period.
Aerospace is the most important application segment, globally. The rapidly increasing air passenger traffic worldwide led to immense pressure on the aviation industry for more aircraft. This resulted in increased demand for aero-engines and turbines, which further resulted in increased demand for the product. This is expected to be a key trend in the industry during the projected years.
Further key findings from the report suggest:
·         Globally, the aerospace application segment dominated the overall industry, and is expected to witness considerable growth during the forecast period, growing at a CAGR of over 6% during the forecast period; the rapid growth can be attributed to growing demand for gas turbines in the aviation industry.
·         Growing adopting of the product in defense and marine application is expected to propel growth over the next eight years. The increasing military expenditures by emerging countries and increasing political instability across the globe are among the key reasons that are expected to impact the procurement of automobiles with advanced equipment and heat management technologies.
·         North America dominated the thermal barrier coatings industry in 2015 with an estimated revenue of over USD 3.5 billion; the industry in this region is projected to grow significantly owing to the increasing technological advancements in the region promoting the adoption of thermal barrier coatings across applications.
·         In the North American industry, the stationary power plants segment is expected to witness the highest growth during the forecast period, projected to grow at a CAGR of nearly 7% in terms of revenue.
·         Globally, Asia Pacific is expected to witness the highest growth during the forecast period in the industry, growing at a CAGR of over 8%. This region is dominated primarily by China, the market in which is expected to witness growth at a CAGR of nearly 9% during the forecast period.
·         Key participants in the given industry include Praxair Surface Technologies, Metallisation Ltd., TST Engineered Coating Solutions, and Precision Coatings, Inc., among others. New product developments and innovation related to improving barrier properties of coatings are expected to strengthen their positions globally.
Browse more reports of this category by Grand View Research: https://www.grandviewresearch.com/industry/paints-coatings-and-printing-inks
Grand View Research has segmented the thermal barrier coatings market on the basis of product, application, technology, coating combination, and region:
Product Outlook (Revenue, USD Million; 2013 - 2024)
·         Metal
·         Ceramic
·         Intermetallic
·         Others
Application Outlook (Revenue, USD Million; 2013 - 2024)
·         Stationary Power Plants
·         Aerospace
·         Automotive
·         Others
Technology Outlook (Revenue, USD Million; 2013 - 2024)
·         Electron-beam Physical Vapor Deposition
·         High Velocity Oxy-fuel
·         Chemical Vapor Deposition
·         Air Plasma
·         Others
Coating Combination Outlook (Revenue, USD Million; 2013 - 2024)
·         Ceramic YSZ
·         Al2O3
·         MCrAiY
·         Mullite-based
·         Others
Regional Outlook (Revenue, USD Million, 2013 - 2024)
·         North America
o    U.S.
·         Europe
o    UK
o    Germany
·         Asia Pacific
o    China
o    India
o    Japan
·         Latin America
o    Brazil
·         Middle East & Africa
o    Saudi Arabia

View press release of this research report by Grand View Research: https://www.grandviewresearch.com/press-release/global-thermal-barrier-coatings-tbc-market
About Grand View Research 
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com


Glucuronolactone Market Is Expected To Reach Usd 436.5 Million By 2024 Due To High Demand For Instant Energy Products Till 2024 : Grand View Research, Inc.

 The global glucuronolactonemarket is expected to reach USD 436.5 million by 2024, according to a new report by Grand View Research, Inc. Growing consumer awareness towards the use of glucuronolactone in various food & beverage products including energy drinks and nutrition supplements will augment industry growth over the next eight years. Growing use of the product for manufacturing pharmaceutical drugs and health supplement is expected to fuel industry growth over the forecast period. The positive outlook towards sports nutrition in light of increasing importance of active lifestyle will promote market expansion.
Food & beverage was the prominent end-use segment and was valued at USD 155.1 million in 2015. Rising health conscious population in the urban region is expected to fuel demand growth over the forecast period. Rising disposable income, increasing health awareness, growing population in various countries including the U.S., Brazil, India and China will promote market growth over the upcoming years.
Further key findings from the report suggest
·         Pharmaceutical application will witness the fastest growth at a CAGR of 7.0% from 2014 to 2024 as a result of increasing usage of glucuronolactone based tablets and supplements to cure arthritis, hepatocirrhosis, and hepatitis. Furthermore, recovery of pharmaceutical industry in the U.S. is expected to drive market growth over the forecast period.
·         North America glucuronolactone market was valued at USD 106.7 million in 2015 and will show significant rise owing to growing demand for energy drinks and nutritional supplements. Moreover, adoption of glucuronolactone as a supplement is also expected to fuel demand over the forecast period.
·         Asia Pacific will witness significant growth at a CAGR of 6.6% from 2016 to 2024 in light of the high level of glucuronolactone producers in China, India, and Japan with a high level of exports. Moreover, abundant availability of the product in China is expected to have a positive impact on the market over the coming years. Growing pharmaceutical sector in China, India, Indonesia, Malaysia Philippines, Singapore, Thailand and Vietnam will stimulate industry expansion.
·         Key manufacturers & exporters in the global glucuronolactone industry include Aceto Corporation, Anhui Fubore Pharmaceutical & Chemical Co., Ltd., Creative Compounds, LLC, Foodchem International Corporation, Hubei Yitai Pharmaceutical Co., Ltd., Merck Millipore Corporation, and Shaoxing Marina Biotechnology Co., Ltd.
·         Merck Millipore Corporation offers glucuronolactone produced by glucose oxidase and used as a nutritional supplement in pharmaceutical industries.

Grand View Research has segmented the global glucuronolactone market on the basis of end-use and region:
Global Glucuronolactone End-Use Outlook (Revenue, USD Million, 2013 - 2024)
·         Food & Beverage
·         Pharmaceuticals
·         Others
Global Glucuronolactone Regional Outlook (Revenue, USD Million, 2013 - 2024)
·         North America
o    U.S.
·         Europe
o    Germany
o    UK
o    France
·         Asia Pacific
o    China
o    India
o    Japan
·         Latin America
o    Brazil
·         MEA
View press release of this research report by Grand View Research: https://www.grandviewresearch.com/press-release/global-glucuronolactone-market
About Grand View Research 
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com


Inulin Market Is Expected To Grow Due To Dairy Industry Growth Till 2020: Grand View Research ,Inc.

Global inulin market is expected to reach USD 2.35 billion by 2020, according to a new study by Grand View Research, Inc. Gaining popularity of prebiotic ingredients on account of rising awareness towards low fat and calorie reduction is expected to fuel inulin market demand over the next six years. U.S. FDA recognized inulin as generally recognized as safe (GRAS) product, which is expected to have a positive impact on market over the next six years.
Food & beverage was the largest application, accounting for over 65% of market volume in 2013. Inulin is being increasingly used in dairy product formulation such as cheese, spoonable yogurts and butter. Dairy industry growth is expected to act as a major driver for inulin market over the forecast period.
Browse full report by Grand View Research : http://www.grandviewresearch.com/industry-analysis/inulin-market
Further key findings from the study suggest:
·         Global inulin market demand was 246.5 kilo tons in 2013 and is expected to exceed 400 kilo tons by 2020, growing at a CAGR of over 9.0% from 2014 to 2020.
·         Use of inulin in dietary supplements is expected to witness substantial growth over the forecast period. Growing infant formula market demand in China and India coupled with announcement of capacity expansion by baby food manufacturers such as Danone and Nestle is expected to positively impact market over the next six years.
·         Europe was the largest inulin market, accounting for over 50% of global volume in 2013. Regulatory scenario aimed at supporting fortification of food with prebiotic ingredients is expected to fuel inulin demand in the region. Growing demand for substitute prebiotics and development of synbiotics are expected to remain key restraining factors for the market.
·         Asia Pacific is anticipated to witness high at an estimated CAGR of over 10% from 2014 to 2020 in terms of revenue owing to positive dairy industry outlook in India, China, Australia and New Zealand. Gaining popularity of functional foods such as infant formula in China, Japan and India is expected to fuel inulin demand over the forecast period.
·         Global inulin market is highly competitive owing to presence of limited companies. Major market players include Jarrow Formulas, Beneo-Orafti, Sensus and Cosucra. Increasing availability of chicory roots in Belgium, France and Spain has forced inulin manufacturers to establish their facilities in the vicinity. New product development and establishment of strategic partnerships between manufacturers and buyers are expected to remain critical success factors for inulin market over the forecast period.
Grand View Research has segmented the global inulin market on the basis of application and region:
Global Inulin Application Outlook (Volume, Kilo Tons; Revenue, USD Million, 2012 - 2020)
·         Food & Beverage
·         Dietary Supplements
·         Pharmaceuticals
·         Others
Global Inulin Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2012 - 2020)
·         North America
·         Europe
·         Latin America
·         Asia Pacific
·         MEA
View press release of this research report by Grand View Research: https://www.grandviewresearch.com/press-release/global-inulin-market
About Grand View Research 
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com



Monday 22 January 2018

Global Carcinoembryonic Antigen (Cea) Expected To Reach Usd 2.56 Billion Due To Increasing Geriatric Population By 2022: Grand View Research, Inc.

Global carcinoembryonicantigen market is expected to reach USD 2.56 Billion by 2022, according to a new study by Grand View Research, Inc. Constant technological advancements pertaining to the development of novel biomarkers which can be used in combination with other biomarkers is expected to boost usage rates over the forecast period. Furthermore, the increasing prevalence of cancer is expected to heighten the demand for effective diagnostic tools. According to the WHO estimates in 2012, global cancer incidences were nearly 14.1 million, which include 6.7 million female patients and 7.4 million male patients. Increasing demand for minimally invasive diagnostics procedures is also expected to play a vital role in determining market growth. Key advantages associated with minimally invasive diagnostics procedures include elevated patient satisfaction levels as they entail minor incision wounds. In addition, these procedures involve relatively lesser hospital stays and therefore, are economically viable and involve fewer post procedure complications.

Further key findings from the study suggest:
·         Colorectal cancer was one of the largest revenue generating application segment of the carcinoembryonic antigen market and was estimated at USD 639.65 million in 2014. Increasing prevalence of colorectal cancer and usage of carcinoembryonic antigen tests at various stages is one of the critical factors accounting for its large share. For instance, in 2012, new cases of colorectal cancer were estimated to be over 93,000 and death due to colorectal cancer is expected to be over 49,700 in the U.S alone.
·         Carcinoembryonic antigen based breast cancer diagnosis is identified as the most lucrative application segment of the market. The market is driven by factors such as growing number of female population above 50 years, growing demand for Hormone Replacement Therapy (HRT) and cosmetic surgeries. Moreover, growing patient awareness levels and the presence of favorable government initiatives are expected to improve treatment rates over the forecast period.
·         North America was the largest regional market in 2014 owing to, the presence of high incidence rates, presence of favorable reimbursement framework, and high consumer awareness levels coupled with relatively higher healthcare expenditure levels.
·         Asia Pacific is anticipated to witness the most lucrative growth over the forecast period. The presence of untapped opportunities, constantly improving healthcare infrastructure, economic development, and improving patient awareness levels are some factors accounting for this rapid growth.
·         Key players operating in carcinoembryonic antigen market include Abbott Diagnostics, Quest Diagnostics, Roche Diagnostics, GenWay Biotech Inc. and Correlogic Systems, Inc. 
Browse more reports of this category by Grand View Research: https://www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented the carcinoembryonic antigen market on the basis of application, and region:
Carcinoembryonic Antigen Application Outlook (Revenue, USD Million, 2012 - 2022)
·         Colorectal cancer
·         Pancreatic cancer
·         Ovarian cancer
·         Breast cancer
·         Thyroid cancer
·         Others
Carcinoembryonic Antigen Regional Outlook (Revenue, USD Million, 2012 - 2022)
·         North America
o    U.S.
o    Canada
·         Europe
o    Germany
o    France
o    Spain
·         Asia Pacific
o    China
o    Japan
o    India
·         MEA
o    South Africa
·         Latin America
o    Brazil
o    Mexico
View Press Release of this research report by Grand View Research: https://www.grandviewresearch.com/press-release/global-carcinoembryonic-antigen-cea-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: 
www.grandviewresearch.com


Medical Billing Outsourcing Market Expected to Raise Till 2024 : Grand View Research, Inc.

The medical billing outsourcing market was valued at USD 6.3 billion in 2015 and is anticipated to reach a value of USD 16.9billion by 2024, according to a new report by Grand View Research, Inc. Large amount of medical code representation for diagnosis and treatment coupled with the presence of multiple payers renders medical billingan intricate part of any medical practice, posing significant challenges. The challenge mounts when this process mandates adherence to the International Classification of Diseases-10th revision (ICD-10) code along with dealing with rising healthcare costs and declining reimbursements. Challenges in managing in-house billing processes include setbacks experienced in the IT structure, untrained staff, billing errors, and lack of proper financial policy in place. In order to curb or alleviate these challenges, several healthcare providers,such as acute care hospitals and clinics/physician offices, prefer outsourcing their medical billing process. According to studies, in 2015, 95% of independent physicians have acknowledged that outsourcing revenue management is the right decision.
Healthcare providers face certain challenges in ascertaining the disadvantages of in-house operation or benefits of outsourcing revenue management operations;hence, they arrived at this decision by implementing thorough assessment and evaluation of the revenue percentage they spend on several billing operations. Currently, the healthcare system is witnessing a subsequent increase in outsourcing of medical billing services by hospitals and physicians. This increase is attributed to factors such as obligatory implementation of complex ICD-10 coding system, increasing healthcare costs, and federal mandate to implement electronic medical records (EMR) to maintain reimbursement levels.
Furthermore, clinics/physician offices are gradually outsourcing their revenue management to cut unnecessary costs and prevent the burden of managing an administrative team to ensure effectivehandling of in-house billing functions.
Further Key Findings From the Study Suggest:
·         North America reported highest revenue growth in this market. The U.S. is witnessing rapid changes in healthcare structure reflected by implementation of new medical coding system known as the ICD-10 coding as well as pressure from the government to implement EMR management system. These changing regulations coupled with rising healthcare costs are major growth drivers for the market in this region.
·         Multispecialty medical groups are implementing consolidation requiring electronic health record (EHR) integration and building large healthcare networks This integrationcreates a need forRevenue CycleManagement (RCM), which in turn demands additional expertise and trained personnel to manage the same. Consolidation of large healthcare practices is expected to be a one of the factors that will help in the growth of the market.
·         Hospitals end-use segment accounts for the largest market share in the medical billing outsourcing market. The ability to gain total control over billing procedures and minimize loss is the main focus of these providers. As healthcare costs rise and profits are decline, RCMoutsourcing is expected to be the best practice considered by these care facilities to manage their revenue.
·         Some of the key players in this industry include Accretive Health, Inc.; Allscripts; Cerner Corporation; EClinicalWorks; Experian Information Solutions, Inc.; GE Healthcare; Genpact; HCL; Kareo; McKesson Corporation; Quest Diagnostics; and The SSI Group.
Browse more reports of this category by Grand View Research: https://www.grandviewresearch.com/industry/healthcare-it
Grand View Research has segmented the medical billing outsourcing market bycomponent, service and end user:
Component Outlook (Revenue, USD Million, 2013 - 2024)
·         In-House
·         Outsourced
Service Outlook (Revenue, USD Million, 2013 - 2024)
·         Front End
·         Middle End
·         Back End
End User Outlook (Revenue, USD Million, 2013 - 2024)
·         Hospitals
·         Physician Offices 
·         Others
Regional Outlook (Revenue, USD Million, 2013 - 2024)
·         North America
o    U.S.
o    Canada
·         Europe
o    Germany
o    UK
·         Asia Pacific
o    Japan
o    India
o    China
·         Latin America
o    Brazil
o    Mexico
·         MEA
o    South Africa
o    Saudi Arabia
View Press Release of this research report by Grand View Research: https://www.grandviewresearch.com/press-release/global-medical-billing-outsourcing-market

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: 
www.grandviewresearch.com